Epoch Biodesign Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Epoch Biodesign Ltd. - overview
Established
2019
Location
London, -, UK
Primary Industry
Environmental Services
About
Based in London, UK, and founded in 2019 by CEO Jacob Nathan, and Douglas Kell, E Epoch Biodesign Ltd. , a. k. a.
Epoch Biodesign is a biodesign company developing natural solutions to scale and industrialize life for a healthy planet. In March 2025, Epoch Biodesign Ltd. raised GBP 18. 3 million in series A funding led by new investor Extantia, with participation from other new investors Inditex, Happiness Capital, Kibo Invest and Day One Ventures.
Returning investor Lowercarbon Capital and other unspecified investors also participated in the round. The company provides the bio-recycling solution, which is a tuneable enzymatic process for recycling plastic waste into circular chemicals. The company will use the March 2025 funding to scale up production of their plastic-eating enzymes.
Current Investors
Amadeus Capital Partners, Plug and Play, BoxGroup
Primary Industry
Environmental Services
Sub Industries
Biotechnology, Pollution Control, Recycling
Website
www.epochbiodesign.com
Verticals
Clean Technology
Company Stage
Series A
Total Amount Raised
Subscriber access only
Epoch Biodesign Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.